Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharma AidsDHA:PHARMAID -2.55%73 Days Inventory is 72.78 as of Mar. 2026, which is 3% above its 10-year median of 70.51. GuruFocus rates DHA:PHARMAID with a GF Score™ of 73/100 and a GF Value™ of BDT758.56 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Pharma Aids ranks better than 89.71% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Pharma Aids's Average Total Inventories for the
three
months ended in Mar. 2026 was BDT66.8 Mil. Pharma Aids's Cost of Goods Sold for the
three
months ended in Mar. 2026 was BDT83.8 Mil.
Hence, Pharma Aids's Days Inventory for the
three
months ended in Mar. 2026 was 72.78.
The historical rank and industry rank for Pharma Aids's Days Inventory or its related term are showing as below:
DHA:PHARMAID'
s Days Inventory Range Over the Past 10 Years
Min: 54.19 Med: 70.51 Max: 85.89
Current: 71.49
During the past 13 years, Pharma Aids's highest Days Inventory was 85.89. The lowest was 54.19. And the median was 70.51.
DHA:PHARMAID's Days Inventory is ranked better than 89.71% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.47
vs DHA:PHARMAID: 71.49
Pharma Aids's Days Inventory
declined
from Mar. 2025 (102.38) to Mar. 2026 (72.78).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Pharma Aids's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.25.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pharma Aids's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.54.
Pharma Aids (DHA:PHARMAID) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Pharma Aids's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pharma Aids's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Pharma Aids Days Inventory Related Terms
Pharma Aids Days Inventory Historical Data
* Premium members only.
The historical data trend for Pharma Aids's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:PHARMAID vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Pharma Aids's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma Aids Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pharma Aids's Days Inventory distribution charts can be found below:
* The bar in red indicates where Pharma Aids's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma Aids (DHA:PHARMAID) has a Days Inventory of 72.78 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pharma Aids and its competitors. This is near median its historical median of 70.51. Over the past decade, Pharma Aids' Days Inventory has ranged from 54.19 to 85.89. According to the industry distribution chart, Pharma Aids ranks #81 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 10.3%.
Is Pharma Aids' Days Inventory too high?
Pharma Aids' current Days Inventory of 72.78 is near median its 10-year median of 70.51. Over the past 10 years, this metric has ranged from a low of 54.19 to a high of 85.89. The Medical Devices & Instruments industry median Days Inventory is 179.47. Pharma Aids' value of 72.78 is 59.4% below this industry median. Based on the distribution chart, Pharma Aids ranks #81 out of 787 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Pharma Aids has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma Aids' Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Pharma Aids ranks #81 out of 787 companies for Days Inventory. This places Pharma Aids in the top 10% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.47. Pharma Aids' value of 72.78 is 59.4% below this benchmark. Historically, Pharma Aids' own Days Inventory has ranged from 54.19 to 85.89 over the past decade. While the company's 10-year median is 70.51 vs. the industry median of 179.47, Pharma Aids has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.47, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma Aids's current Days Inventory of 72.78 is 59.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pharma Aids and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma Aids's current Days Inventory is 72.78, which is near median its own 10-year median of 70.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Aids stock overvalued right now?
Based on GuruFocus' analysis, Pharma Aids (DHA:PHARMAID) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT758.56, compared to a current price of BDT644.70 — trading 15% below its estimated fair value. The current Days Inventory is 72.78, which is near median its 10-year median of 70.51 and 59.4% below the Medical Devices & Instruments industry median of 179.47. Pharma Aids' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Pharma Aids (DHA:PHARMAID), the current Days Inventory is 72.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma Aids (DHA:PHARMAID) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma Aids stock appears to be undervalued.
The current stock price of BDT644.70 is trading 15% below its estimated GF Value™ of BDT758.56.
GuruFocus considers Pharma Aids to be Modestly Undervalued.
Key valuation signals for DHA:PHARMAID:
Days Inventory: 72.78 (near median its 10-year median of 70.51)
GF Value™: BDT758.56 vs. price of BDT644.70 (15% below fair value)
Industry Position: 59.4% below the Medical Devices & Instruments median (#81 of 787)
No single metric tells the full story. See the DHA:PHARMAID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma Aids Ltd is a Bangladesh-based company engaged in the manufacturing of neutral glass ampoules, USP Type-I. Ampoules are used by pharmaceutical companies for filling liquid injections. The company produces different sizes of ampoules from 1ml to 25ml, in Clear and Amber color, and in Amber color, and of both Open Mouth (Form B and C) and Close Mouth (Form D, Din and Marzocchi type).
73GF Score
Get the complete analysis for DHA:PHARMAID
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:PHARMAID has been successfully added to your 
